HomeCompareWACMY vs MRK

WACMY vs MRK: Dividend Comparison 2026

WACMY yields 4.63% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WACMY wins by $4007.98M in total portfolio value
10 years
WACMY
WACMY
● Live price
4.63%
Share price
$4.75
Annual div
$0.22
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4008.04M
Annual income
$3,848,418,743.87
Full WACMY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — WACMY vs MRK

📍 WACMY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWACMYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WACMY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WACMY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WACMY
Annual income on $10K today (after 15% tax)
$393.68/yr
After 10yr DRIP, annual income (after tax)
$3,271,155,932.29/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, WACMY beats the other by $3,271,147,603.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WACMY + MRK for your $10,000?

WACMY: 50%MRK: 50%
100% MRK50/50100% WACMY
Portfolio after 10yr
$2004.05M
Annual income
$1,924,214,271.00/yr
Blended yield
96.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WACMY
No analyst data
Altman Z
4.6
Piotroski
8/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WACMY buys
0
MRK buys
0
No recent congressional trades found for WACMY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWACMYMRK
Forward yield4.63%2.76%
Annual dividend / share$0.22$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$4008.04M$56.8K
Annual income after 10y$3,848,418,743.87$9,798.13
Total dividends collected$3996.77M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WACMY vs MRK ($10,000, DRIP)

YearWACMY PortfolioWACMY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,626$926.32$11,206$366.19+$420.00WACMY
2$14,453$2,013.02$12,650$502.35+$1.8KWACMY
3$20,142$4,677.51$14,407$694.19+$5.7KWACMY
4$33,737$12,184.54$16,585$967.82+$17.2KWACMY
5$74,245$38,146.03$19,342$1,363.89+$54.9KWACMY
6$236,353$156,911.43$22,913$1,947.19+$213.4KWACMY
7$1,186,577$933,679.08$27,662$2,823.89+$1.16MWACMY
8$10,031,137$8,761,500.11$34,159$4,173.35+$10.00MWACMY
9$149,178,863$138,445,545.95$43,337$6,308.80+$149.14MWACMY
10$4,008,040,127$3,848,418,743.87$56,776$9,798.13+$4007.98MWACMY

WACMY vs MRK: Complete Analysis 2026

WACMYStock

Wacom Co., Ltd. develops, manufactures, and sells electronic devices and related software worldwide. It provides input components and sensor systems to manufacturers of smartphones, tablets, and notebook PCs. The company also offers pen computers, such as MobileStudio Pro; pen displays, including Wacom One, Cintiq 13HD, Cintiq 22HD, Cintiq 22HD touch, Cintiq 27QHD, Cintiq 27QHD touch, Wacom Cintiq, and Wacom Cintiq Pro; pen tablets comprising Wacom Intuos, Wacom Intuos Pro, and Wacom Intuos Pro Paper; and smart pads consisting of Bamboo Slate and Bamboo Folio. In addition, it provides Bamboo Ink, Bamboo Ink Plus, Bamboo Sketch, Bamboo Solo, Bamboo Duo, Bamboo Fineline, and Bamboo Alpha styluses; and apps and services, such as Bamboo Paper, Inkspace, and Wacom Notes. Wacom Co., Ltd. was incorporated in 1983 and is headquartered in Kazo, Japan.

Full WACMY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this WACMY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WACMY vs SCHDWACMY vs JEPIWACMY vs OWACMY vs KOWACMY vs MAINWACMY vs JNJWACMY vs ABBVWACMY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.